Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000939
Chunk: 65

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 65
---
 that such filing or use would require premature disclosure of information that could materially adversely
affect the Company; provided, however, that in the event the Investor owns Purchase Shares at the time of any such suspension of use of
the registration statement, the Company shall use reasonable best efforts to make such registration statement available for the resale
of such securities by the Investor as soon as practicable thereafter. The initial Registration Statement shall register only Registrable
Securities. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such Registration Statement and
any amendment or supplement to such Registration Statement and any related prospectus prior to its filing with the SEC, and the Company
shall give due consideration to all such comments. The Investor acknowledges that it will be identified in the initial Registration Statement
(and in any New Registration Statement) as an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and the Investor
shall furnish all information reasonably requested by the Company for inclusion therein. The Company shall use its commercially reasonable
efforts to have the Registration Statement and any amendment declared effective by the SEC at the earliest practicable date. Subject to
any grace periods set forth in the Purchase Agreement, the Company shall use commercially reasonable efforts to keep the Registration
Statement effective pursuant to Rule 415 promulgated under the Securities Act and available for the resale by the Investor of all of the
Registrable Securities covered thereby at all times until the earlier of (i) the date on which the Investor shall have resold all the
Registrable Securities covered by such Registration Statement and (ii) the date of termination of the Purchase Agreement if as of such
termination date the Investor holds no Registrable Securities (or, if applicable, the date on which such securities cease to be Registrable
Securities after the date of termination of the Purchase Agreement) (the “”). The effective Registration
Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light
of the circumstances in which they were made, not misleading.

| 2 |

b. . The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant
to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales
of the Registrable